Profile
I am a Research Fellow in Medical Statistics based in the Primary Care Epidemiology Unit in the Centre for Primary Care. My work primarily focuses on uptake, safety and effectiveness of COVID-19 and other routine vaccines in different groups across the UK population, including people with blood cancer, immunocompromised people, children and pregnant people. I initially started this role in 2022 at the University of Oxford, before moving to QMUL with the team in 2025.
Prior to joining the Primary Care Epidemiology team, I worked in the Nuffield Department of Women's and Reproductive Health at Oxford as a Statistical Programmer & Data Analyst, where my research focused on non-communicable diseases, including hypertension, cardiovascular disease and cancer.
I have expertise in the analysis of large healthcare datasets and a variety of statistical methods including survival analysis, multi-level modelling, self-controlled case series analysis and individual-level patient data (IPD) meta-analysis. I also have significant experience in the analysis of linked electronic healthcare records. Additionally, I have a strong interest in Patient and Public Involvement (PPI) in research and have been involved in setting up a departmental Young Person Advisory Group at Oxford.
Alongside my role at QMUL I am currently undertaking a DPhil in Primary Health Care at the University of Oxford, where my work focuses on health inequalities in people with learning disabilities. I am currently in the second year of my studies.
Research
Research Interests:
My broad research interest is using big data to address health inequalities. In particular, my PhD focuses on reducing avoidable deaths in people with learning disabilities. My other research interests include uptake, safety and effectiveness of vaccinations and medications.
Publications
Safety outcomes following COVID-19 vaccination and infection in 5.1 million children in England. DOI: 10.1038/s41467-024-47745-z. Link: https://www.nature.com/articles/s41467-024-47745-z
Uptake, effectiveness and safety of COVID-19 vaccines in individuals at clinical risk due to immunosuppressive drug therapy or transplantation procedures: a population-based cohort study in England. DOI: 10.1186/s12916-024-03457-1. Link: https://link.springer.com/article/10.1186/s12916-024-03457-1
Effectiveness and safety of COVID-19 vaccination in people with blood cancer. DOI: 10.1016/j.ejca.2024.113603. Link: https://www.ejcancer.com/article/S0959-8049(24)00079-0/fulltext
Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis. DOI: 10.1016/s1470-2045(21)00033-4. Link: https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(21)00033-4/fulltext
Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis. DOI: 10.1016/s0140-6736(21)01921-8. Link: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01921-8/fulltext